Ambient Light-Activatable Luminescent Particle-Embedded Conformal Patch for Photochemical Tissue Bonding and Photobiomodulated Healing.
Summary
The authors developed a stretchable patch containing room-light-activatable luminescent particles that converts ambient light into red emission to drive photochemical tissue bonding and photobiomodulation. In preclinical models the patch promoted collagen crosslinking, accelerated wound sealing and healing; a small clinical study on normal facial skin reported acute improvement in viscoelastic recovery and reduced superficial erythema after a single PBM treatment.
Key Findings
- A conformal elastomeric patch with room-light-activatable luminescent particles converts ambient broadband light into red emission that activates photosensitizers.
- In vitro and in vivo preclinical models: the patch promoted PTB, collagen crosslinking, fibroblast proliferation, M1/M2 polarization, and accelerated sealing and healing of linear and circular wounds.
- A pilot clinical study on normal human facial skin showed acute improvement in viscoelastic recovery and reduction of superficial erythema after a single PBM treatment with the patch.
Clinical Implications
Potential to simplify and broaden access to photochemical tissue bonding and photobiomodulation for wound closure and skin rejuvenation without dedicated light sources; could enable at-home or clinic workflows that do not require lasers/LED rigs. Requires larger controlled clinical trials to confirm efficacy, safety, dosing, and long-term outcomes.
Why It Matters
This study presents a clinically translatable, power-free photonic device that enables continuous phototherapy during daily life and includes human pilot data — a significant step toward ambient-light-driven wound care and aesthetic PBM applications.
Limitations
- Clinical data are from a small, uncontrolled pilot on normal facial skin; sample size and subject characteristics are not provided in the abstract.
- Long-term safety, optimal dosing (exposure time/intensity), and efficacy in diseased or wounded human cohorts remain untested.
Future Directions
Larger randomized controlled clinical trials in wound and aesthetic indications to define dosing, efficacy endpoints, and safety; mechanistic studies on photosensitizer activation kinetics under ambient spectra; device optimization for regulatory translation.
Study Information
- Study Type
- Case series
- Research Domain
- Treatment
- Evidence Level
- III - Non-randomized interventional/early clinical study with preclinical data; hypothesis-generating translational evidence.
- Study Design
- OTHER